FACULTY POSITIONS IN CHINA

Job Post for Novo Nordisk (China) R&D Center

Novo Nordisk (www.novonordisk.com), an international healthcare company headquartered in Denmark, is manufacturing and marketing biopharmaceutical products in 180 countries. Novo Nordisk is the world leader in diabetes care and has leading positions within haemophilia management, growth hormone therapy and hormone replacement therapy. The company is currently expanding into inflammatory diseases. Novo Nordisk employs c. 26,000 employees in 79 countries, including 4,600 people in R&D, and invests annually 1.5 billion USD in R&D. Beijing Novo Nordisk Pharmaceuticals Science and Technology Co. Ltd (also known as Novo Nordisk China R&D Center) is an integrated part of Novo Nordisk's R&D organization focusing on the discovery and development of new treatments for inflammation and haemostasis disorders; also, it's the first R&D organization set up by an international pharmaceutical company in China.

Building on its extensive expertise in protein expression and purification, this center actively pursues novel drug target identification and evaluation in the area of immunotherapy against inflammatory diseases. We now have excellent opportunities for a few highly motivated scientists, who plan to advance their careers in China.